David Cachia, MD
Research Focus - Translational Research in Neuro-oncology
- Identification and evaluation of drugs and drug combinations that improve clinical outcomes for glioma patients
- Understanding molecular biology and immunological profile of gliomas and their microenvironment
- Interest in developing collaborations with basic researchers to translate findings to the clinic for the treatment of glioblastoma
Representative Publication
Das, A, Henderson FC, Jr, Alshareef M, et al. MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells. Clin Trans Oncol. 2021;23(3):612-619.